Chi-Chun Wong

Title: Chi-Chun Wong: Innovator in Non-Alcoholic Fatty Liver Disease Research

Introduction

Chi-Chun Wong is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of non-alcoholic fatty liver diseases (NAFLD). His innovative work has led to the development of a patented method that enhances the understanding and management of this condition.

Latest Patents

Chi-Chun Wong holds a patent for his invention titled "Squalene epoxidase in the diagnosis and treatment of non-alcoholic fatty liver diseases." This invention provides a method for diagnosing or prognosing NAFLD by detecting the expression level of the Squalene Epoxidase (SQLE) gene. Additionally, it includes a kit and device useful for these methods. Furthermore, the invention offers a treatment approach for NAFLD by suppressing SQLE gene expression or activity. This patent highlights his innovative approach to tackling a significant health issue.

Career Highlights

Chi-Chun Wong is affiliated with The Chinese University of Hong Kong, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential impact on public health, particularly in addressing liver diseases that affect a large population.

Collaborations

Chi-Chun Wong has collaborated with notable colleagues, including Jun Yu and Dabin Liu. These partnerships have facilitated the advancement of research in the field and have contributed to the successful development of his patented methods.

Conclusion

Chi-Chun Wong's contributions to the diagnosis and treatment of non-alcoholic fatty liver diseases exemplify the importance of innovation in medical research. His patented methods and collaborative efforts continue to pave the way for advancements in healthcare.